Last Price
932.06
Today's Change
+21.37 (2.34%)
Day's Change
911.18 - 932.24
Trading Volume
2,162,105
Market Cap
885 Billion
Shares Outstanding
950 Million
Avg Volume
3,171,350
Avg Price (50 Days)
905.74
Avg Price (200 Days)
804.26
PE Ratio
114.93
EPS
8.11
Earnings Announcement
30-Oct-2024
Previous Close
910.69
Open
916.04
Day's Range
911.1845 - 932.1
Year Range
547.61 - 972.53
Trading Volume
1,894,786
1 Day Change
2.35%
5 Day Change
4.67%
1 Month Change
-0.32%
3 Month Change
-1.72%
6 Month Change
24.00%
Ytd Change
57.39%
1 Year Change
52.67%
3 Year Change
300.40%
5 Year Change
763.82%
10 Year Change
1372.91%
Max Change
33069.40%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—General
Description:
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.